| 000 | 03081nam a22003495i 4500 | ||
|---|---|---|---|
| 999 |
_c81698 _d81698 _x1 |
||
| 001 | 81698 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230221040151.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 141028s2015 ne | s |||| 0|eng d | ||
| 020 | _a9789401794695 | ||
| 024 | 7 |
_a10.1007/978-94-017-9469-5 _2doi |
|
| 040 |
_bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aQK495.L25 _b2015 EB |
|
| 245 | 0 | 0 |
_aDan Shen (Salvia miltiorrhiza) in Medicine _nVolume 1, _pBiology and Chemistry _cedited by Xijun Yan. |
| 264 | 1 |
_aDordrecht, Netherlands _bSpringer _c2015 |
|
| 300 |
_a1 recurso en línea (XXX, 212 p.) _b94 ilustraciones, 2 ilustraciones en color |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 505 | 0 | _aMateria Medica and Plant Resource -- Distribution and Habitat of Danshen -- Biological Characters of Danshen -- A Study on the Cultivation of Danshen -- Danshenâ€{u3829}n vitro Culture -- Genetics and Breeding of Danshen -- Water Soluble Components of Danshen -- Liposoluble chemical constituents in Danshen. | |
| 520 | _aThis book reviews research on Dan Shen, compiles data from clinical trials and biological experiments, and summarizes the latest research advances. It covers the medicinal herb, herbal pieces, and new proprietary drugs that contain it; it also covers simple and compound, traditional and contemporary formulas, and addresses a broad range of subjects, including: standardized cultivation;Â{u08A9}odiversity; effective substances and their biological activities; quality control; and clinical trials. The book goes on to present the clinical trials on Dantonic, especially focusing on its therapeutic effects for coronary heart disease. It discusses compound prescriptions and compatibilities, from the herbal piece level to composition level, and describes approaches to research on modern Chinese medicine. Â{u05AF}lume 1 describes the biology and chemistry of Dan Shen, while Volume 2 focuses on pharmacology and quality control. Volume 3 describes the clinical research on Dan Shen. ÂŤitor Xijun Yan is the President of Tianjin Tasly Group and a Member of the TCM Standardization Technical Committee. Gathering contributions from more than 100 authors working in the field of pharmaceutical and clinical research, the book presents and analyzes the available information from multiple aspects, reflects the current status of Dan Shen research, and offers an essential reference work for further research and development. | ||
| 988 | _aEBOOK, EBSPRINGER | ||
| 650 | 7 |
_aFarmacología _2embne _9137893 |
|
| 650 | 7 |
_9671889 _aSalvias _2embne |
|
| 700 | 1 |
_aYan, Xijun _eeditor literario _994275 _0Local |
|
| 710 | 2 |
_aSpringerLink (Online service) _0Local _9106996 |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-94-017-9469-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b11/2020 _dz _eIG _feng _gne _h0 |
||